Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19

DOI record: { "DOI": "10.1172/jci151697", "ISSN": [ "1558-8238" ], "URL": "http://dx.doi.org/10.1172/jci151697", "alternative-id": [ "10.1172/JCI151697" ], "author": [ { "ORCID": "http://orcid.org/0000-0002-6877-1712", "affiliation": [], "authenticated-orcid": false, "family": "Ganesh", "given": "Ravindra", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0003-2781-7507", "affiliation": [], "authenticated-orcid": false, "family": "Pawlowski", "given": "Colin F.", "sequence": "additional" }, { "affiliation": [], "family": "O’Horo", "given": "John C.", "sequence": "additional" }, { "affiliation": [], "family": "Arndt", "given": "Lori L.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-4723-689X", "affiliation": [], "authenticated-orcid": false, "family": "Arndt", "given": "Richard F.", "sequence": "additional" }, { "affiliation": [], "family": "Bell", "given": "Sarah J.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-3337-5645", "affiliation": [], "authenticated-orcid": false, "family": "Bierle", "given": "Dennis M.", "sequence": "additional" }, { "affiliation": [], "family": "Borgen", "given": "Molly Destro", "sequence": "additional" }, { "affiliation": [], "family": "Hanson", "given": "Sara N.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-3414-0832", "affiliation": [], "authenticated-orcid": false, "family": "Heyliger", "given": "Alexander", "sequence": "additional" }, { "affiliation": [], "family": "Larsen", "given": "Jennifer J.", "sequence": "additional" }, { "affiliation": [], "family": "Lenehan", "given": "Patrick J.", "sequence": "additional" }, { "affiliation": [], "family": "Orenstein", "given": "Robert", "sequence": "additional" }, { "affiliation": [], "family": "Puranik", "given": "Arjun", "sequence": "additional" }, { "affiliation": [], "family": "Speicher", "given": "Leigh L.", "sequence": "additional" }, { "affiliation": [], "family": "Tulledge-Scheitel", "given": "Sidna M.", "sequence": "additional" }, { "affiliation": [], "family": "Venkatakrishnan", "given": "A.J.", "sequence": "additional" }, { "affiliation": [], "family": "Wilker", "given": "Caroline G.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-7796-7680", "affiliation": [], "authenticated-orcid": false, "family": "Badley", "given": "Andrew D.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-5248-0227", "affiliation": [], "authenticated-orcid": false, "family": "Razonable", "given": "Raymund R.", "sequence": "additional" } ], "container-title": [ "Journal of Clinical Investigation" ], "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2021, 8, 19 ] ], "date-time": "2021-08-19T16:12:14Z", "timestamp": 1629389534000 }, "deposited": { "date-parts": [ [ 2021, 9, 30 ] ], "date-time": "2021-09-30T18:25:22Z", "timestamp": 1633026322000 }, "funder": [ { "DOI": "10.13039/100000871", "award": [ "NA" ], "doi-asserted-by": "publisher", "name": "Mayo Clinic" } ], "indexed": { "date-parts": [ [ 2021, 12, 13 ] ], "date-time": "2021-12-13T15:49:43Z", "timestamp": 1639410583854 }, "is-referenced-by-count": 3, "issn-type": [ { "type": "electronic", "value": "1558-8238" } ], "issue": "19", "issued": { "date-parts": [ [ 2021, 10, 1 ] ] }, "journal-issue": { "issue": "19", "published-online": { "date-parts": [ [ 2021, 10, 1 ] ] }, "published-print": { "date-parts": [ [ 2021, 10, 1 ] ] } }, "language": "en", "link": [ { "URL": "https://www.jci.org/articles/view/151697/files/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "232", "original-title": [], "prefix": "10.1172", "published": { "date-parts": [ [ 2021, 10, 1 ] ] }, "published-online": { "date-parts": [ [ 2021, 10, 1 ] ] }, "published-print": { "date-parts": [ [ 2021, 10, 1 ] ] }, "publisher": "American Society for Clinical Investigation", "reference": [ { "article-title": "An EUA for bamlanivimab-a monoclonal antibody for COVID-19", "first-page": "880", "issue": "9", "journal-title": "JAMA", "key": "B1", "volume": "325", "year": "2020" }, { "article-title": "An EUA for bamlanivimab etesevimab for COVID-19", "first-page": "49", "issue": "1621", "journal-title": "Med Lett Drugs Ther", "key": "B2", "volume": "63", "year": "2021" }, { "article-title": "An EUA for casirivimab imdevimab for COVID-19", "first-page": "201", "issue": "1614", "journal-title": "Med Lett Drugs Ther", "key": "B3", "volume": "62", "year": "2020" }, { "DOI": "10.1101/2020.09.30.318972", "doi-asserted-by": "crossref", "key": "B4", "unstructured": "Jones BE, et al. LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection [preprint]. https://doi.org/10.1101/2020.09.30.318972 Posted on bioRxiv October 9, 2020" }, { "key": "B5", "unstructured": "Coronavirus (COVID-19) update: FDA revokes emergency use authorization for monoclonal antibody bamlanivimab. News release. U.S. Food and Drug Administration; April 16, 2021. Accessed April 24, 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab" }, { "DOI": "10.1056/NEJMoa2029849", "doi-asserted-by": "publisher", "key": "B6" }, { "DOI": "10.1016/j.mayocp.2021.03.010", "doi-asserted-by": "publisher", "key": "B7" }, { "key": "B8", "unstructured": "Bhimraj A, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/ Updated June 25, 2021. Accessed January 30, 2021" }, { "key": "B9", "unstructured": "National Institutes of Health. The COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Bamlanivimab for the Treatment of COVID-19. https://www.covid19treatmentguidelines.nih.gov/statement-on-bamlanivimab-eua/ Updated August 4, 2021. Accessed January 30, 2021" }, { "key": "B10", "unstructured": "Vora S. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with COVID-19. https://pids.org/2020/11/19/sars-cov-2-neutralizing-antibody-ly-cov555-in-outpatients-with-covid-19/ Updated November 19, 2020. Accessed January 30, 2021" }, { "DOI": "10.1093/ofid/ofab254", "doi-asserted-by": "publisher", "key": "B11" }, { "DOI": "10.1177/21501327211019282", "article-title": "Influence of social and cultural factors on the decision to consent for monoclonal antibody treatment among high-risk patients with mild-moderate COVID-19", "author": "Bierle", "doi-asserted-by": "crossref", "journal-title": "J Prim Care Community Health", "key": "B12", "volume": "12", "year": "2021" }, { "article-title": "Real-world experience of bamlanivimab for COVID-19: a case-control study", "author": "Kumar", "journal-title": "Clin Infect Dis", "key": "B13" }, { "DOI": "10.1093/ofid/ofab255", "doi-asserted-by": "publisher", "key": "B14" }, { "DOI": "10.1111/jgs.17090", "doi-asserted-by": "publisher", "key": "B15" }, { "DOI": "10.1016/j.mayocp.2020.06.051", "article-title": "Telemedicine consultations and follow-up of patients with COVID-19", "author": "Crane", "doi-asserted-by": "crossref", "first-page": "S33", "issue": "9S", "journal-title": "Mayo Clin Proc", "key": "B16", "volume": "95", "year": "2020" }, { "DOI": "10.1016/j.mayocpiqo.2020.12.003", "doi-asserted-by": "publisher", "key": "B17" }, { "DOI": "10.1001/jama.2020.6775", "doi-asserted-by": "publisher", "key": "B18" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "doi-asserted-by": "publisher", "key": "B19" }, { "DOI": "10.1111/j.1467-6419.2007.00527.x", "doi-asserted-by": "publisher", "key": "B20" }, { "DOI": "10.1093/ije/dyy120", "doi-asserted-by": "publisher", "key": "B21" }, { "DOI": "10.1002/sim.3697", "doi-asserted-by": "publisher", "key": "B22" }, { "DOI": "10.1016/j.jclinepi.2013.01.013", "article-title": "Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research", "author": "Stuart", "doi-asserted-by": "crossref", "first-page": "S84", "issue": "8 Suppl", "journal-title": "J Clin Epidemiol", "key": "B23", "volume": "66", "year": "2013" }, { "DOI": "10.3109/00952990.2011.600386", "doi-asserted-by": "publisher", "key": "B24" }, { "DOI": "10.25080/Majora-92bf1922-011", "doi-asserted-by": "crossref", "key": "B25", "unstructured": "Seabold S, Perktold J. Statsmodels: econometric and statistical modeling with Python. Paper presented at: 9th Python in Science Conference; June 28–July 3, 2010; Austin, Texas, USA. Accessed August 16, 2021. https://doi.org/10.25080/Majora-92bf1922-011" }, { "DOI": "10.1038/s41592-019-0686-2", "doi-asserted-by": "publisher", "key": "B26" }, { "key": "B27", "unstructured": "lifelines. Version 0.26.0. Cam Davidson-Pilon; 2021. Accessed August 16, 2021. https://github.com/CamDavidsonPilon/lifelines" }, { "key": "B28" } ], "reference-count": 28, "references-count": 28, "relation": {}, "score": 1, "short-container-title": [], "short-title": [], "source": "Crossref", "subject": [ "General Medicine" ], "subtitle": [], "title": [ "Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19" ], "type": "journal-article", "volume": "131" }